Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence
Despite the expanding therapeutic options available to cancer patients, therapeutic resistance, disease recurrence, and metastasis persist as hallmark challenges in the treatment of cancer. The rise to prominence of generative artificial intelligence (GenAI) in many realms of human activities is com...
Saved in:
Main Author: | Youcef Derbal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/11795549241311408 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
by: Goran Bencina, et al.
Published: (2023-06-01) -
New Horizons In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
by: Zein El Amir
Published: (2023-06-01) -
Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes
by: Wayne G. Brisbane, et al.
Published: (2025-01-01) -
RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01) -
Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer
by: Andris Romašovs, et al.
Published: (2019-01-01)